COF
NVS icon

Capital One Financial’s Novartis NVS Stock Holding History

Capital One Financial’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,316
Closed -$549K – 233
2020
Q3 		$549K Sell
6,316
-591
-9% -$51.2K 0.07% 152
2020
Q2 		$603K Sell
6,907
-2,569
-27% -$222K 0.08% 167
2020
Q1 		$782K Buy
+9,476
New +$845K 0.13% 137

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Capital One Financial's NVS Position: Q4 2020 in Review

Capital One Financial sold out of Novartis (NVS) in Q4 2020, closing a stake of 6,316 shares — an estimated $549K sold.

Capital One Financial first reported a position in NVS in Q1 2020 and held it in 3 quarters. The position peaked at $782K in Q1 2020. 1,176 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

  • Capital One Financial reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
  • Capital One Financial sold 6,316 Novartis shares in Q4 2020, an estimated $549K.
  • Capital One Financial first reported a position in Novartis in Q1 2020 and held it in 3 quarters.
  • Capital One Financial's Novartis position peaked at $782K in Q1 2020.
  • 1,176 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on Capital One Financial's 13F filing for Q4 2020, filed 11 Feb 2021.